Kevin DeGeeter Recent News
Ladenburg Downgrades Cempra Following FDA's Complete Response Letter
Kindred Biosciences Is 'Setting The Pace In Animal Health Biologics'
Ladenburg Initiates BioTime Shares With Buy, $6 Price Target
Ladenburg Says No Need For Novavax To Rerun Failed Drug Study
Sequenom Can't Go Back; Ladenburg Analysts Downgrade To Sell
The Wall Street Research Making Waves Today